Bristol Myers Squibb is warming up for the FIFA World Cup 2026 with a new media campaign, launching its “Won’t Lose” ad ahead ...

The U.S. Supreme Court has temporarily reinstated online access to the abortion pill mifepristone.  | The U.S. Supreme Court ...

After topping up its long-running operations in Puerto Rico with plans for a $650 million investment last year, Amgen is ...

After submitting plans to cut 114 jobs tied to its U.S. headquarters in New Jersey in March, Novartis late last month added a ...

A union strike of thousands of workers is still ongoing at Korean CDMO Samsung Biologics, costing the company over a million ...

For the first time in its 16-year analysis of the pharma industry, Deloitte found obesity drugs are the largest contributor ...

A strategic marketing lead at CDMO Axplora, Arsalan Khan is also a chemical and pharmaceutical engineer, a published author and an avid tennis player.  | Rising Stars: A strategic marketing lead at ...

Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...

A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 trial has sent Summit Therapeutics’ shares tumbling, ...

Shortly after laying out $75 million upfront for Corstasis Therapeutics and its congestive heart failure edema drug Enbumyst, ...

Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak sales projection for Pluvicto, even as the company has ...

Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition (PDF) ...